|
1-(9H-beta-carbolin-1-yl)ethanone
|
69598 |
|
|
1-(9H-pyrido[3,4-b]indol-1-yl)ethanone
|
69598 |
|
|
1-Oxaspiro-[4,5]-2,6,10,10-tetramethyl-6-decene
|
89598 |
|
|
1-oxaspiro-2,6,10,10-tetramethyl[4.5]dec-6-ene
|
89598 |
|
|
Rha4NFoalpha1-2Rha4NFoalpha1-2Rha4NFoalpha1-2Rha4NFoalpha1-2Rha4NFoalpha-yl
|
59598 |
|
|
alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-(1->2)-alpha-D-Rha4NFo-yl group
|
59598 |
|
|
O(3)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl]-L-threonine residue
|
139598 |
|
|
O(3)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc]-L-Thr(1-) residue
|
139598 |
|
|
EC 2.3.3.8 (ATP citrate synthase) inhibitors
|
149598 |
|
|
acetyl-CoA:oxaloacetate acetyltransferase (isomerizing, ADP-phosphorylating) inhibitor
|
149598 |
|
|
acetyl-CoA:oxaloacetate acetyltransferase (isomerizing, ADP-phosphorylating) inhibitors
|
149598 |
|
